Inactivation of SNF5 cooperates with p53 loss to accelerate tumor formation in Snf5+/−;p53+/− mice

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Molecular Carcinogenesis

• Publication date

  2009-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/mc.20568PMID 19676100PMCID PMC3527082
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The impact of p53 and p73 on aneuploidy and cancer.

  2008cited by this paper
• Loss of the Epigenetic Tumor Suppressor SNF5 Leads to Cancer without Genomic Instability

  2008cited by this paper
• Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis

  2008cited by this paper
• Evidence of a four‐hit mechanism involving SMARCB1 and NF2 in schwannomatosis‐associated schwannomas

  2008cited by this paper
• Tumor-specific cooperation of retinoblastoma protein family and Snf5 inactivation.

  2007cited by this paper
• Germline mutation of INI1/SMARCB1 in familial schwannomatosis.

  2007cited by this paper
• Increased DNA Damage Sensitivity and Apoptosis in Cells Lacking the Snf5/Ini1 Subunit of the SWI/SNF Chromatin Remodeling Complex

  2006influential reference
• Functional interaction of the retinoblastoma and Ini1/Snf5 tumor suppressors in cell growth and pituitary tumorigenesis.

  2006cited by this paper
• Cancer-associated mutations in chromatin remodeler hSNF5 promote chromosomal instability by compromising the mitotic checkpoint.

  2005cited by this paper
• Chromosome mechanisms and INI1 inactivation in human and mouse rhabdoid tumors.

  2005cited by this paper
• Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation.

  2005cited by this paper
• Expression of pericyte, mesangium and muscle markers in malignant rhabdoid tumor cell lines: Differentiation‐induction using 5‐azacytidine

  2003cited by this paper
• Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5.

  2002cited by this paper
• The role of INI1 and the SWI/SNF complex in the development of rhabdoid tumors: meeting summary from the workshop on childhood atypical teratoid/rhabdoid tumors.

  2002cited by this paper
• Drug resistance in malignant rhabdoid tumor cell lines

  2002cited by this paper
• Disruption of Ini1 Leads to Peri-Implantation Lethality and Tumorigenesis in Mice

  2001cited by this paper
• Mutations of the p53 gene in malignant rhabdoid tumors of soft tissue and the kidney: immunohistochemical and DNA direct sequencing analysis

  2001cited by this paper
• Selective Inactivation of p53 Facilitates Mouse Epithelial Tumor Progression without Chromosomal Instability

  2001cited by this paper
• Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis

  2001cited by this paper
• Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice.

  2000cited by this paper
• The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression

  2000cited by this paper
• Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors.

  1999cited by this paper
• Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers.

  1999cited by this paper
• Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations.

  1999cited by this paper
• hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors.

  1999cited by this paper
• P53 Is Essential for Developmental Neuron Death as Regulated by the TrkA and p75 Neurotrophin Receptors

  1998cited by this paper
• Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer

  1998cited by this paper
• Extrarenal rhabdoid tumors of soft tissue: a clinicopathologic and immunohistochemical study of 18 cases.

  1998cited by this paper
• Gene Expression of Malignant Rhabdoid Tumor Cell Lines by Reverse Transcriptase‐Polymerase Chain Reaction

  1997cited by this paper
• Evidence for p53-Mediated Modulation of Neuronal Viability

  1996cited by this paper
• Immunohistochemical and cytogenetic findings in malignant rhabdoid tumor.

  1996cited by this paper
• Tumor spectrum analysis in p53-mutant mice.

  1994influential reference
• Induction versus progression of brain tumor development: differential functions for the pRB- and p53-targeting domains of simian virus 40 T antigen

  1994cited by this paper
• Spontaneous and carcinogen–induced tumorigenesis in p53–deficient mice

  1993cited by this paper
• Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

  1992influential reference
• Malignant rhabdoid tumor of the kidney and soft tissues. Evidence for a diverse morphological and immunocytochemical phenotype.

  1989cited by this paper
• Malignant soft tissue neoplasms with the histologic features of renal rhabdoid tumors: an ultrastructural and immunohistochemical study.

  1985cited by this paper
• Rhabdoid tumors of the kidney contain mesenchymal specific and epithelial specific intermediate filament proteins.

  1984cited by this paper
• Paravertebral malignant rhabdoid tumor in infancy in vitro studies of a familial tumor

  1983cited by this paper
• Infantile sarcoma with intracytoplasmic filamentous inclusions: Distinctive tumor of possible histiocytic origin

  1982cited by this paper
• Ultrastructure of malignant rhabdoid tumor of the kidney. A distinctive renal tumor of children.

  1981cited by this paper
• Histopathology and prognosis of Wilms tumor Results from the first national wilms' tumor study

  1978cited by this paper

• Telomeres: Dysfunction, Maintenance, Aging and Cancer

  2023cites this paper
• SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors With Complex Copy Number Alterations andTP53Mutations May Represent the First Clinical Manifestation of Li-Fraumeni Syndrome.

  2022cites this paper
• Atypical teratoid rhabdoid tumor (ATRT): disease mechanisms and potential drug targets

  2022cites this paper
• Preclinical In Vivo Modeling of Pediatric Sarcoma—Promises and Limitations

  2021cites this paper
• SWI/SNF chromatin remodeling complex is required for initiation of sex-dependent differentiation in mouse germline

  2021cites this paper
• Haploinsufficiency Interactions of RALBP1 and TP53 in Carcinogenesis

  2021cites this paper
• p53 Is Not Required for High CIN to Induce Tumor Suppression

  2020cites this paper
• Translational Genomics of Malignant Rhabdoid Tumours: Current Impact and Future Possibilities.

  2020cites this paper
• EWS–FLI1 modulated alternative splicing of ARID1A reveals novel oncogenic function through the BAF complex

  2019cites this paper
• High Frequency of Ovarian Cyst Development in Vhl2B/+;Snf5+/- Mice.

  2018cites this paper
• Case-based review: atypical teratoid/rhabdoid tumor.

  2018cites this paper
• Rlip depletion prevents spontaneous neoplasia in TP53 null mice

  2018cites this paper
• Generation of a mouse model of atypical teratoid/rhabdoid tumor of the central nervous system through combined deletion of Snf5 and p53.

  2015cites this paper
• Use of clinical next‐generation sequencing to identify melanomas harboring SMARCB1 mutations

  2015cites this paper
• Chromatin remodeling: from transcription to cancer.

  2014cites this paper
• Alterations in TP53 gene – Implications in Tumorigenesis Process and Prognosis in Central Nervous System Cancer

  2014cites this paper
• Therapeutic Significance of Chromatin Remodeling Complexes in Cancer

  2014cites this paper
• The Expanding Family of SMARCB1(INI1)-deficient Neoplasia: Implications of Phenotypic, Biological, and Molecular Heterogeneity

  2014cites this paper
• The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium

  2013cites this paper
• Establishment and characterization of MRT cell lines from genetically engineered mouse models and the influence of genetic background on their development

  2013cites this paper
• Connective tissue tumors

  2012cites this paper
• SRG3/mBAF155 stabilizes the SWI/SNF-like BAF complex by blocking CHFR mediated ubiquitination and degradation of its major components.

  2012cites this paper
• Alteration to the SWI/SNF complex in human cancers

  2011cites this paper
• p16INK4A and p14ARF Tumor Suppressor Pathways Are Deregulated in Malignant Rhabdoid Tumors

  2011influential citation
• Cellular and Molecular Life Sciences the Role of Genetics in the Establishment and Maintenance of the Epigenome

  year unknowncites this paper
• SHORT COMMUNICATION High Frequency of Ovarian Cyst Development in Vhl 2B/ þ ;Snf5 þ / (cid:2) Mice

  year unknowncites this paper